Anlon Healthcare has received a disclosure from Neomile Asset Managers Private Limited regarding a significant reduction in shareholding under SEBI regulations. The Mumbai-based asset management firm has sold a substantial portion of its equity stake in the healthcare company through open market transactions.

Share Sale Details

Neomile Asset Managers, along with its associated entities Neomile Growth Fund – Series I and Neomile Corporate Advisory Limited, disposed of 13,07,378 equity shares of Anlon Healthcare. The transaction represents 2.46% of the company's total share capital and was executed through open market sales between November 6, 2025, and January 9, 2026.

Shareholding Changes

The sale has resulted in a notable change in Neomile's ownership structure in Anlon Healthcare. Prior to this transaction, the asset management firm and its associated entities held a combined stake of 7.62% in the company.

Regulatory Compliance

The disclosure was made in accordance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011. The notification was simultaneously submitted to both the National Stock Exchange of India Limited (NSE) and BSE Limited, where Anlon Healthcare's shares are listed under the scrip codes AHCL and 544497 respectively.

The disclosure was signed by CA Rashesh Shah, Director of Neomile Asset Managers Private Limited, and submitted on January 9, 2026. The document confirms that Neomile and its associated entities do not belong to the promoter or promoter group of Anlon Healthcare.

Company Information

Anlon Healthcare Limited, incorporated under CIN U24230GJ2013PLC077543, operates from its registered office in Rajkot, Gujarat. The company's shares continue to trade on both major Indian stock exchanges, with the total equity share capital remaining unchanged at 5,31,51,500 shares post-transaction.

Anlon healthcare has received a regulatory disclosure from Neomile Asset Managers Pvt. Ltd. regarding the substantial sale of shares by its associated investment entities. The transaction represents a significant reduction in the asset manager's stake in the healthcare company through open market operations.

Transaction Details

The disclosure reveals that Neomile Growth Fund – Series I and Neomile Corporate Advisory Limited, acting as persons acting in concert (PAC), disposed of shares in Anlon Healthcare between November 6, 2025, and January 9, 2026. The following table summarizes the key transaction parameters:

Shareholding Changes

The sale resulted in a notable reduction in Neomile's collective stake in Anlon Healthcare. The shareholding pattern before and after the transaction shows:

The entities involved in the transaction maintained no encumbrances, warrants, or convertible securities before or after the sale. All holdings were in the form of ordinary shares carrying voting rights.

Regulatory Compliance

The disclosure was made in accordance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. Neomile Asset Managers submitted the required documentation to:

• National Stock Exchange of India Ltd. (NSE Scrip Code: AHCL)
• BSE Limited (BSE Scrip Code: 544497)
• Anlon Healthcare Limited directly

The disclosure was signed by CA Rashesh Shah, Director of Neomile Asset Managers Pvt. Ltd., on January 9, 2026, from Mumbai.

Entity Information

The disclosure identified the key entities involved in the transaction:

Both entities confirmed they do not belong to the promoter or promoter group of Anlon Healthcare Limited. The transaction represents a strategic portfolio adjustment by the asset management firm and its associated investment vehicles in the healthcare sector company.